S
Sesen Bio Inc
F:PCBK
Sesen Bio Inc
F:PCBK
Price:
0.5124
EUR
28.1%
Market Closed
Market Cap:
€103.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sesen Bio Inc
F:PCBK
|
US |
|
P
|
Planisware SA
PAR:PLNW
|
FR |
|
CLARIVATE PLC
NYSE:CLVT
|
UK |
|
U
|
Urban Outfitters Inc
XETRA:UOF
|
US |
|
D
|
Digital Media Solutions Inc
OTC:DMSL
|
US |
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
US |
|
S
|
Sta Lucia Land Inc
XPHS:SLI
|
PH |
|
E
|
enGene Holdings Inc
NASDAQ:ENGN
|
CA |
|
F
|
FoodNamoo Inc
KOSDAQ:290720
|
KR |
|
A
|
Adyen NV
F:1N8
|
NL |
|
Nihon Parkerizing Co Ltd
TSE:4095
|
JP |
|
China Citic Bank Corp Ltd
OTC:CHBJF
|
CN |
|
Uni-Asia Group Ltd
SGX:CHJ
|
HK |
|
G
|
GSI Technology Inc
XBER:ZS6
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PCBK.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PCBK
Multiples-Based Value
Not Available
Multiples Across Competitors
PCBK Competitors Multiples
Sesen Bio Inc Competitors
Sesen Bio Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
S
|
Sesen Bio Inc
F:PCBK
|
103.9m EUR | 3.1 | -6.2 | 0.4 | 0.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.6 | 17.7 | 13.1 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 32.9 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
